Evaluation of parameters related to the probability of leukemic progression in patients with lower-risk myelodysplastic syndrome

Several prognostic factors such as intermediate karyotype, presence of 5-9% bone marrow blasts and platelet count

Source: Clinical Lymphoma, Myeloma and Leukemia - May 9, 2018 Category: Hematology Authors: Jose F. Falantes, Francisco J. M árquez-Malaver, Cristina Calderón-Cabrera, Begoña Pedrote, María L. Martino, Jose González, Ildefonso Espigado, Jose A. Pérez-Simón Tags: Original Study Source Type: research